Search

Clovis Oncology, a new biotech startup focused on commercializing anti-cancer agents, disclosed today that it has raised $145M for the firm. The firm, which has offices in San Francisco but is based in Boulder, Colorado, said the funding came from Domain Associates, New Enterprise Associates (NEA), Versant Ventures, Aberdare Ventures, Abingworth, Frazier Healthcare Ventures, ProQuest Investments and the Company's management team. The firm was founded by former executives and founders of Pharmion, which was acquired in 2008 by Celegene for $2.9 billion.
posted on Thursday, May 21, 2009 (Link to more information)

Related companies:
Clovis Oncology

Related stories:
> SuccessFactors Buys Learning Management Software Firm
> McKesson Buys US Oncology
> Rocket Fuel Acquired By Sizmek For $145M
> ThoughtSpot Adds $145M For AI Search Tools
> 3-V Biosciences Finds $20M

---

silicontap.com Home